Antibody production
-
Antibody production
Custom anti-GPCR antibodies
Oumayma Rouis
-
The untapped potential of bispecific antibody therapies
Bispecific antibody therapy makes use of bispecific antibodies for a variety of purposes. This large family of versatile biotherapeutics… Read More
-
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
An autoimmune disorder and natural curiosity led Dr. Louisa James to a fascinating career in immunology. Dr. James is currently… Read More
-
The role of point-of-care tests in tracking and curbing the COVID-19 pandemic
Coordinated strategies, efficient tracking, and vaccination are key to ensure a safe return to normal during the COVID-19 pandemic. But… Read More
-
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
An unorthodox project idea led Dr. Mara Freire, a researcher at CICECO – Aveiro Institute of Materials, from the Chemistry… Read More
-
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Dr. Melanie Conrad, head of the Reproductive Immunology Lab at the Charité Medical University in Berlin, Germany, has dedicated her… Read More
-
How the phage display technology is boosting the production of valuable bispecific antibodies
Bispecific antibodies are valuable therapeutics due to their unique ability to engage different epitopes or antigens and thus modulate the… Read More
-
Is genetic immunization a one-size-fits-all solution to accelerate polyclonal antibody generation?
Polyclonal antibodies are valuable tools for research as secondary reagents or therapy as antivenom drugs. However, their production has largely… Read More
-
Can antibody therapeutics serve as effective tools to treat and alleviate aggressive rare diseases?
Although rare diseases are characterized by a generalized low incidence in the global population, collectively, over 7,000 different conditions affect… Read More
-
What makes antibody therapeutics uniquely fitted to fight autoimmune disorders?
Autoimmune disorders afflict almost 10% of the global population, with a particular incidence in young and middle-aged women. Despite the… Read More
